Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The United States Antimony Corporation (UAMY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. UAMY’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on the NYSE American and NYSE Texas, so investors can review a range of filings, including Form 8-K current reports that detail material events and corporate developments.
Recent Form 8-K filings for United States Antimony cover topics such as entry into material definitive agreements, including a five-year supply agreement with a U.S. industrial fabric manufacturer for antimony trioxide, and capital markets transactions under shelf registration statements and sales agreements. Other 8-Ks report on operational updates, preliminary revenue guidance, and proposals related to potential acquisitions, as well as the appointment of new independent directors and the formation of board committees.
Filings also disclose information about conference calls and press releases reporting financial and operational results for periods such as the third quarter and nine months ended September 30, 2025. These documents outline revenues, gross profit, operating expenses, net loss, and balance sheet data, along with narrative discussion of antimony and zeolite sales and capital expenditures for smelter expansion and mineral rights purchases.
On this page, Stock Titan pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that help explain the significance of each filing. Investors can quickly scan Form 8-K disclosures for key points on contracts, financing, governance changes, and operational guidance, and then dive into the full text when more detail is needed. For those tracking UAMY’s role in antimony, zeolite, and critical minerals, these filings provide an official record of the company’s regulatory and financial reporting.
United States Antimony Corporation reported that it has closed on the acquisition of a critical minerals flotation facility located in Radersburg, Montana. The facility, which is fully operational and situated between Helena and Bozeman, was acquired on January 16, 2026 for $4.75 million in cash, representing an immediate investment outflow.
The company has also budgeted approximately $2 million in future capital expenditures to make specific improvements to the newly acquired property and equipment. Details of the transaction and planned upgrades are described further in a related press release furnished as an exhibit.
United States Antimony Corp director Jon R. Marinelli reported new equity-based awards tied to his service with the company. He was granted derivative rights over 24,509 shares of common stock through a time-based restricted stock unit award under the Amended & Restated 2023 Equity Incentive Plan. One-third, or 8,170 shares, will vest on December 4, 2026, with additional one‑third portions vesting on December 4, 2027 and December 4, 2028, if he continues in service.
Marinelli was also granted stock options covering 15,182 shares of common stock at an exercise price of $6.12 per share. These options vest in three equal installments of 5,061 shares on December 4, 2026, December 4, 2027, and December 4, 2028, contingent on his continued service through each vesting date.
United States Antimony Corporation filed a current report to let investors know it has issued a new shareholder letter. The company states that the letter, dated January 5, 2026, has been provided as Exhibit 99.1 to this report and is incorporated by reference. The information is furnished under Regulation FD, which means it is intended to share the same information with all investors at the same time rather than being treated as formally filed financial statements.
United States Antimony Corporation (UAMY) reported that its Board of Directors has appointed Jon R. Marinelli as a new director, effective November 24, 2025. With his addition, the Board increases to seven members, of which five are independent, and he will also serve as Chairman of a newly formed Finance Committee.
Marinelli brings more than 25 years of experience in capital markets, M&A, and strategic advisory work, including leadership roles at BMO Capital Markets and Deutsche Bank’s natural resources group, and has advised on over $285 billion in transactions. He will serve until the next annual shareholder meeting under the company’s standard non-employee director compensation program, and there are no related-party transactions requiring disclosure.
United States Antimony Corporation furnished an 8-K under Item 2.02 to provide the transcript of its conference call discussing financial and operational results for the third quarter and nine months ended September 30, 2025. A replay is available on the company’s website until November 26, 2025.
The transcript is attached as Exhibit 99.1 and is being furnished, not filed, which limits potential liability under the Exchange Act. The filing also includes customary forward‑looking statements cautions.
United States Antimony Corporation furnished a press release reporting its financial and operational results for the third quarter and nine months ended September 30, 2025.
The press release was provided as Exhibit 99.1 to this Form 8-K under Item 2.02 and is incorporated by reference. The information in Item 2.02, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The company also included customary forward‑looking statements language.
United States Antimony Corporation reported sharply higher sales and larger losses in its Q3 results. Revenue rose to $8,701,951 from $2,572,178 a year ago, driven by antimony products, while gross profit reached $2,013,442. The company posted a net loss of $4,780,700 as operating expenses jumped, including non‑cash share‑based compensation.
Year to date, revenue was $26,227,079. The balance sheet strengthened with cash and cash equivalents of $18,338,679 and held‑to‑maturity U.S. Treasury Strips at $20,157,393 amortized cost. Operating cash flow was $(6,220,686), offset by $42,415,350 provided by financing activities, including an at‑the‑market sale and a registered direct offering; warrant exercises added cash as well.
The company disclosed a five‑year IDIQ contract with the DLA Strategic Materials for antimony metal ingots, with a maximum value of $245 million through September 2030. An initial delivery order for 315,000 pounds is valued at approximately $10 million; no revenue has been recognized yet. Inventory increased to $8,413,161, PP&E to $28,121,338, and management booked a $469,822 gain on early termination of a Montana lease.
United States Antimony Corporation entered into a five-year supply agreement with a large U.S. industrial fabric manufacturer for antimony trioxide, a key ingredient in flame‑retardant materials. The agreement was executed on November 7, 2025 and reflects a multi‑year commercial commitment for product sales.
The company announced the deal via press release on November 11, 2025. The purchasing and supply agreement is filed as Exhibit 10.1, with a press release attached as Exhibit 99.1.
United States Antimony Corporation (UAMY): Patrick Dugan and the Estate of Lydia Dugan filed Amendment No. 4 to Schedule 13D, an exit filing, after selling shares and reducing their beneficial ownership below 5%.
The group reports beneficial ownership of 5,700,560 shares, representing 4.1% of the class, based on 138,878,411 shares outstanding as of October 13, 2025. Dispositions disclosed include 1,022,089 shares at $9.41 per share (transaction effected on October 28, 2025) and 1,346,278 shares at $9.29 per share (transaction effected on October 29, 2025). The filing states they ceased to be beneficial owners of more than five percent of the issuer’s securities.
United States Antimony Corporation announced the schedule for releasing its Third Quarter and Nine Months Ended September 30, 2025 financial and operating results. The company will host a conference call and webcast on November 12, 2025 at 4:15 p.m. Eastern time.
Access details are provided in a press release attached as Exhibit 99.1. The information was furnished under Item 8.01 and is not deemed filed under Section 18 of the Exchange Act.